Prophylactic granulocyte colony-stimulating factor in critically ill patients
- 1 April 1998
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 26 (4) , 636-637
- https://doi.org/10.1097/00003246-199804000-00005
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhageCritical Care Medicine, 1998
- GRANULOCYTE COLONY-STIMULATING FACTOR AND MODULATION OF INFLAMMATORY CELLS IN SEPSISClinics in Chest Medicine, 1996
- Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in ratsJournal of Applied Physiology, 1996
- Clinical comparison of the BACTEC 9000 Standard Anaerobic/F and Lytic/F blood culture mediaDiagnostic Microbiology and Infectious Disease, 1996
- Nosocomial Bloodstream Infection in Critically III PatientsJAMA, 1994
- Reduced expression of neutrophil CD11b and CD16 after severe traumatic injuryJournal of Surgical Research, 1992
- Down-regulation of Homing ReceptorsPublished by Wolters Kluwer Health ,1991
- Inhibition of Colony-Stimulating Factor (CSF) Production by Postburn Serum: Negative Feedback Inhibition Mediated by LactoferrinPublished by Wolters Kluwer Health ,1988
- Neutrophil Activation in SepsisArchives of Surgery, 1988
- High risk of hospital-acquired infection in the ICU patientCritical Care Medicine, 1982